Author:
Yang Ju Dong,Chaiteerakij Roongruedee,Roberts Lewis R.
Reference173 articles.
1. Berman C. Primary carcinoma of the liver. Bull N Y Acad Med. 1959;35:275–92.
2. Blumberg BS, Larouze B, London WT, Werner B, Hesser JE, Millman I, Saimot G, Payet M. The relation of infection with the hepatitis B agent to primary hepatic carcinoma. Am J Pathol. 1975;81:669–82.
3. Vogel CL, Anthony PP, Mody N, Barker LF. Hepatitis-associated antigen in Ugandan patients with hepatocellular carcinoma. Lancet. 1970;2:621–4.
4. Larouze B, Saimot G, Lustbader ED, London WT, Werner BG, Payet M. Host responses to hepatitis-B infection in patients with primary hepatic carcinoma and their families. A case/control study in Senegal, West Africa. Lancet. 1976;2:534–8.
5. Maupas P, Werner B, Larouze B, Millman I, London WT, O’Connell A, Blumberg BS. Antibody to hepatitis-B core antigen in patients with primary hepatic carcinoma. Lancet. 1975;2:9–11.